Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laterre, E. C.
Right arrow Articles by Sfaello, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laterre, E. C.
Right arrow Articles by Sfaello, Z.
NEUROLOGY 1970;20:982
© 1970 American Academy of Neurology

Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system

E. C. Laterre, M.D., A. Callewaert, M.D., J. F. Heremans, M.D. and Z. Sfaello, M.D.

From the Laboratory of Neurochemistry and Department of Experimental Medicine, University of Louvain, Belgium

SUMMARYCSF protein electrophoresis in agar gel was performed in 2,043 patients. Among them, 323 patients were classified as having MS. The essential feature of the gamma globulins in CSF from MS patients and other inflammatory CNS diseases resided in their restricted heterogeneity distribution. This peculiar electrophoretic pattern occurs in 75.2 to 86.9% of MS patients, depending upon the diagnostic category (possible, probable, or definite). The differences were significant. In MS patients there was also a positive correlation between the degree of disability and the frequency of gamma pattern when Grade I and Grade III were compared, but no correlation was found between the duration and course of the disease on the one hand and the CSF gamma globulin changes on the other hand.

In the other patients, this frequency varied between 2. to 5.1%, except for the group with inflammatory CNS diseases in which it reached 39.6%. The diagnostic value of the method employed is discussed and emphasized.

Dr. Laterre's address is Department of Neurology-Neurosurgery, University Hospital St. Raphael, Voer des Capucins, 35, Kapucijnenvoer, Louvain, Belgium.

This work was supported in part by the Fonds de la Recherche Scientifique Medicale.

Submitted for publication Oct. 5, 1969; resubmitted Jan. 28, 1970; accepted Feb. 16, 1970.

The expert assistance of Miss H. Heulle is gratefully acknowledged.




This article has been cited by other articles:


Home page
NeurologyHome page
G. Davies, G. Keir, E. J. Thompson, and G. Giovannoni
The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study
Neurology, April 8, 2003; 60(7): 1163 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
I Cortese, S Capone, R Tafi, L M. Grimaldi, A Nicosia, and R Cortese
Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients
Multiple Sclerosis, February 1, 1998; 4(1): 31 - 36.
[Abstract] [PDF]


Home page
LupusHome page
G. Linardaki, F. Skopouli, C. Koufos, and H. Moutsopoulos
Subclinical multisystemic autoimmunity presenting as a progressive myelopathy
Lupus, January 1, 1997; 6(8): 675 - 677.
[Abstract] [PDF]


Home page
Arch NeurolHome page
V. K. Kostulas, A. Henriksson, and H. Link
Monosymptomatic Sensory Symptoms and Cerebrospinal Fluid Immunoglobulin Levels in Relation to Multiple Sclerosis
Arch Neurol, May 1, 1986; 43(5): 447 - 451.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. V. Iivanainen, W. Wallen, M. E. Leon, J. Keski-Oja, V. P. Calabrese, M. A. Krasny, E. A. Waybright, J. B. Selhorst, J. W. Harbison, D. L. Madden, et al.
Micromethod for Detection of Oligoclonal IgG in Unconcentrated CSF by Polyacrylamide Gel Electrophoresis
Arch Neurol, July 1, 1981; 38(7): 427 - 430.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Iivanainen, P. Leinikki, E. Taskinen, I. C. Shekarchi, D. Madden, and J. Sever
CSF Oligoclonal Bands, Immunoglobulins, and Viral Antibodies in Progressive Myoclonus Epilepsy
Arch Neurol, April 1, 1981; 38(4): 206 - 208.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Fischer-Williams and R. C. Roberts
Cerebrospinal Fluid Proteins and Serum Immunoglobulins: Occurrence in Multiple Sclerosis and Other Neurological Diseases: Comparative Measurement of {upsilon}-Globulin and the IgG Class
Arch Neurol, December 1, 1971; 25(6): 526 - 534.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. Link and R. Muller
Immunoglobulins in Multiple Sclerosis and Infections of the Nervous System
Arch Neurol, October 1, 1971; 25(4): 326 - 344.
[Abstract] [PDF]


Home page
Arch NeurolHome page
W. W. Tourtellotte, B. Tavolato, J. A. Parker, and P. Comiso
Cerebrospinal Fluid Electroimmunodiffusion: An Easy, Rapid, Sensitive, Reliable, and Valid Method for the Simultaneous Determination of Immunoglobulin-G and Albumin
Arch Neurol, October 1, 1971; 25(4): 345 - 350.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by AAN Enterprises, Inc.